Qualification opinion of novel methodologies in the predementia stage of Alzheimer’s disease: cerebrospinal-fluid-related biomarkers for drugs affecting amyloid burden

  • Email
  • Help

Document details

Download document Qualification opinion of novel methodologies in the predementia stage of Alzheimer’s disease: cerebrospinal-fluid-related biomarkers for drugs affecting amyloid burden
Reference number EMA/CHMP/SAWP/102001/2011
Status adopted
First published 16/05/2011
Last updated 16/05/2011